ArticleDiscover oncology2026

Clinical efficacy and cardiac toxicity associated with first-line dabrafenib plus trametinib in advanced BRAF V600_K601delinsE-mutated lung adenocarcinoma: a case report and literature review.

Lu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.